BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 25, 1998
View Archived Issues
Celsion and Duke University enter oncology alliance
Read More
Group C meningococcal conjugate vaccine shown safe and immunogenic in phase II
Read More
Another market introduction for cidofovir
Read More
More telomerase inhibitors added to the Geron pipeline
Read More
New agents for inhibiting EGF receptor-mediated abnormal cell growth
Read More
RCT reports new HLE inhibitors
Read More
Searle conducts AIDS research, identifies protease inhibitors
Read More
NeoRx begins phase I trial of Pretarget technology in lymphoma
Read More
Phase II trial data reported for levormeloxifene
Read More
AxyS enters agreement with Parke-Davis
Read More
Positive phase II results for GMK vaccine presented at NCI-EORTC meeting
Read More
Interim results from dose-escalating phase I/II trials of PRO-542 presented at Bio '98
Read More
TOBI efficacy maintained in longer term studies
Read More
CMB-401, an immunoconjugate for the targeted treatment of EOC
Read More
Anthracenedione analogue BBR-2778 moves to phase I testing
Read More
Lilly's continued focus in the area of postmenopausal syndrome and estrogen-related disorders
Read More
Selective 5-HT1F agonists claimed to be particularly useful for migraine, chronic pain
Read More
Safe and effective agents for diabetes and diabetic complications described by ADIR
Read More
Stem cell factor BLA scheduled for review by CBER advisory committee in late July
Read More
Cationic peptides exert selective antitumor activity against sensitive and resistant cell lines
Read More
Pharmacopeia acquires Molecular Simulations
Read More
First patients being treated with bombesin/GRP antagonist RC-3095
Read More
Schering-Plough initiates phase I with oral antithrombotic
Read More
Flavone acetic acid analogue suppresses tumor blood perfusion, patient study shows
Read More
Favorable early clinical trial results presented for AERx-delivered insulin at diabetes congress
Read More
Broadened use of Taxotere in breast cancer cleared by FDA
Read More
Enbrel BLA accepted for review and assigned priority review status
Read More
Pharmacokinetics and metabolism of TAT-59 investigated in animals
Read More
